ARENA 2: A Clinical Study for dRTA
We are currently looking for people in the United States and Canada to take part in the ARENA 2 Study, a clinical study for patients of all ages with distal renal tubular acidosis (dRTA).
The ARENA 2 study involves the medication ADV7103, an orally administrated investigational drug taken twice daily.
The clinical study is now enrolling patients who:
Are from 6 months to 65 years of age
Have been diagnosed with dRTA
Did not develop dRTA through an autoimmune disorder or medical therapy
CLINICAL STUDY SITES
There will be 15 clinics within the United States and Canada participating in this study.
PARTICIPATE IN THIS CLINICAL STUDY
Find out if you may qualify to enroll in this clinical study.